• Event Type: The document is a regulatory filing containing the transcript of an Earnings Conference Call held to discuss the company's unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27).
• Date and Time: The earnings conference call was held on Monday, August 10, 2026. A specific start time was not mentioned in the transcript.
• Stated Purpose: The primary purpose of the event was to discuss the Q1 FY27 financial results and provide a business and strategic update to analysts and investors.
• Timing Relative to Earnings: The call was held after the earnings announcement. The results for the quarter ended June 30, 2026, were announced prior to this call.
• Management Participants: The following management representatives participated in the call:
- Mr. Manish Grover – Managing Director
- Mr. Ankush Kaushal – Whole-Time Director
- Mr. Nanak Chand – Chief Financial Officer
The call was moderated by Ms. Soumya Chhajed from Go India Advisors.
• Availability of Materials: The company confirmed that the transcript of the earnings conference call has been made available on the company's website. The specific URL provided is: https://jeenasikho.com/wp-content/uploads/2026/08/Jeena-Sikho-Q1FY27-Earning-Call-Transcript.pdf.
• UPSI Statement: The moderator began the call with a standard cautionary statement, reminding participants that the discussions may include forward-looking statements and must be viewed in conjunction with the risks pertaining to the business. There was no explicit statement that no Unpublished Price Sensitive Information (UPSI) would be shared.
• Financial Period Discussed: The call focused exclusively on the results for Q1 FY27 (the quarter ended June 30, 2026).
• Forward-Looking Statements & Strategic Themes: Management extensively discussed forward-looking strategies, including:
- A long-term vision to build a preventive healthcare "ecosystem" or "health operating system."
- A target to achieve a turnover of INR 3,000 crores within 3-5 years and a PAT of INR 1,000 crores.
- A plan to expand operational bed capacity from 2,400 to 3,000-3,500 in FY27 and 7,000-10,000 beds in 3-5 years.
- The launch of a new ultra-luxury wellness center ("Jeena Sikho Premium") in Manali, with operations expected to commence in September-October 2026.
- A strategy to increase patient engagement through recurring care models, technology, and an app.
- An intention to start admitting Ayushman Bharat scheme patients at discounted rates to increase occupancy, ahead of formal empanelment.
Additional Notes Section
• Attachments: The primary document is the transcript itself. The regulatory filing letter states "Encl: A/A," suggesting an attachment was included, which is the transcript.
• Financial Data Disclosure: Financial data was disclosed in the transcript. Key figures from Q1 FY27 discussed include:
- Revenue from Operations: INR 224 Crores (29% YoY growth)
- EBITDA: INR 92 Crores (17% YoY growth)
- PAT: INR 65 Crores
- EBITDA Margin: 41%
- PAT Margin: 28%
- Breakdown: Ayurveda Healthcare Services revenue at ~INR 105 Cr; Product Business revenue grew 47% YoY.
- Other Income included a one-time component of ~INR 7 Cr (INR 5 Cr from warrant valuation and INR 2.5 Cr capital gains).
• Operational Metrics: Several key operational metrics were shared:
- Total unique patient/customer connections in Q1: 534,000 (up from 487,000 in Q4 FY26).
- IPD Patients: 11,500 (33% YoY increase)
- Day Care Volume: 19,400 (31% YoY increase)
- Operational Bed Capacity: 2,400 beds with 59% occupancy.
• Logistical Details: Dial-in numbers and access codes were not included in the provided transcript excerpt.